UbiVac
is an Oregon-based biotechnology company that researches and develops novel immunotherapies for the treatment of cancer... Read moreUbiVac
is an Oregon-based biotechnology company that researches and develops novel immunotherapies for the treatment of cancer... Read more
News
May 18, 2026
Citybizlist
UbiVac: UbiVac Adds Immunotherapy Pioneer Walter Urba to Scientific Advisory Board
Dec 10, 2025
EIN Presswire
Press Release: UbiVac : Cancer's 'Dark Matter' Outshines Neoantigens in Landmark Debate
Nov 18, 2025
EIN Presswire
Press Release: UbiVac : UbiVac CEO Presents Pioneering Dark-Matter Cancer Vaccine Advances at Parker Institute for Cancer Immunotherapy Workshop
May 08, 2025
EIN Presswire
Press Release: UbiVac : UbiVac CEO Participates in Cancer Vaccine Panel at SynBioBeta & Wilson Sonsini Investment Forum
May 05, 2025
EIN Presswire
Press Release: UbiVac : UbiVac Presents 1st Report of In Vivo Generated T Cell Receptor (TCR) to Dark Genome-Derived Cancer's Dark Matter
Mar 19, 2025
EIN Presswire
Press Release: UbiVac : UbiVac to present on Dark Genome-derived Dark Matter/Proteome Cancer Immunotherapy at Spring 2025 Venture Forum
Nov 08, 2024
EIN Presswire
Press Release: UbiVac : Promising Phase Ib Data for UbiVac's DPV-001 in Combination Immunotherapy for Head and Neck Squamous Cell Cancer
Jun 12, 2024
sec
UbiVac: UBIVAC|
Received $50K in Debt Funding
Apr 04, 2024
UbiVac Youtube Channel
UbiVac posted a video ""Cancer Vaccines Containing Dark Matter" Dr. Bernard Fox, NCI Distinguished Lecture Series 01/11/24" on YOUTUBE
Oct 31, 2023
SEC
UbiVac: UbiVac Received $100K in Equity Funding
UbiVac Competitors
1
2
3
4
5
6
7
8
9
10